Healthcare -
Biotechnology - NASDAQ - US
$ 18.13
6.27 %
$ 1.44 B
Market Cap
-4.2
P/E
VRDN - TOTAL ASSETS
Total Assets VRDN - Viridian Therapeutics, Inc.
490 M
LAST VALUE
55.16%
2 YEAR CAGR
49.28%
5 YEAR CAGR
63.14%
10 YEAR CAGR